+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Immuno Oncology Assays Market by Technology Type, Application, End User, Product, Indication - Global Forecast to 2030- Product Image
Immuno Oncology Assays Market by Technology Type, Application, End User, Product, Indication - Global Forecast to 2030- Product Image
Sale

Immuno Oncology Assays Market by Technology Type, Application, End User, Product, Indication - Global Forecast to 2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5337689
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The immuno oncology assays market is entering a period of strategic transformation, driven by innovation in assay technologies and evolving global regulatory and trade landscapes. Senior leaders navigating the cancer diagnostics and therapy ecosystem face unprecedented challenges and opportunities as the demand for scalable, high-precision solutions surges across research, diagnostics, and clinical care settings.

Market Snapshot: Immuno Oncology Assays Market Size and Growth

The Immuno Oncology Assays Market grew from USD 7.21 billion in 2024 to USD 8.33 billion in 2025. It is expected to continue growing at a CAGR of 15.30%, reaching USD 16.95 billion by 2030.

Scope & Segmentation

This comprehensive analysis spans all major subdivisions of the immuno oncology assays landscape, offering competitive insight for decision-makers. The market is examined by product type, technological approach, application arena, end-user profile, cancer indication, and regional coverage.

  • Technology Types: Flow Cytometry (Conventional and Spectral), Immunoassay (ELISA, Multiplex Immunoassay), Immunohistochemistry (Automated and Manual), Mass Cytometry, Next Generation Sequencing (Targeted Panel, Whole Exome, Whole Genome)
  • Applications: Companion Diagnostics (Predictive and Prognostic), Clinical and Preclinical Research
  • End Users: Academic and Research Institutes, Diagnostic Laboratories, Hospitals and Clinics, Pharmaceuticals and Biotech Companies
  • Product Categories: Consumables (Probes, Antibodies, Reagents, Kits), Instruments (Automated Systems, Platform-Based Instruments)
  • Cancer Indications: Breast Cancer, Hematologic Cancers, Lung Cancer, Melanoma
  • Geographical Regions: Americas (including the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, and others), Asia-Pacific (China, India, Japan, Australia, etc.)
  • Key Players: Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Agilent Technologies, F. Hoffmann-La Roche Ltd, and others

Key Takeaways for Senior Decision-Makers

  • Emerging assay technologies such as spectral flow cytometry and multiplex systems are setting new standards in immune profiling, increasing research depth and clinical applicability.
  • Digital pathology platforms, enhanced by artificial intelligence, are streamlining tissue-based analyses and supporting data-rich decision environments in clinical workflows.
  • Strategic segmentation reveals dynamic growth across both consumables and instrumentation markets—each demanding tailored supply, support, and innovation strategies to address evolving end-user needs.
  • Regional market heterogeneity, particularly in Europe, Middle East, and Africa, mandates localization strategies that factor in regulatory variation and procurement models for effective market access.
  • Cross-industry partnerships and supplier diversification are mitigating cost pressures and logistical constraints, enabling organizations to respond with agility to both operational and geopolitical challenges.
  • Validated, regulatory-compliant assays and responsive technical support will be critical differentiators as organizations seek to capture market share in a rapidly expanding segment.

Tariff Impact: US Immuno Oncology Assay Trade

Revised US tariffs in 2025 prompted significant cost increases for key assay components, including reagents, probes, and capital equipment. These adjustments have led manufacturers and laboratory operators to reassess supplier portfolios, negotiate long-term contracts, and pursue nearshoring strategies to reduce logistical risks. While near-term innovation may feel constrained due to increased operational costs, the shift is fostering regional manufacturing investments and supply chain resilience.

Methodology & Data Sources

The research employs a hybrid approach combining in-depth interviews with market participants—such as assay developers, laboratory directors, and regulatory experts—with extensive secondary analysis of peer-reviewed literature and regulatory documents. Data from varied sources were triangulated for accuracy. Final conclusions were peer-reviewed and refined to ensure actionable, reliable insights.

Why This Report Matters

  • Enables executive teams to develop targeted growth strategies across technologies, regions, and end-user groups in the immuno oncology assays market.
  • Delivers actionable recommendations for mitigating regulatory, tariff, and supply chain risks while capitalizing on emerging technological advancements.
  • Supports informed capital allocation and partnership decisions using segment-level market, technology, and competitive insights.

Conclusion

This report offers an integrated view of the immuno oncology assays market, equipping stakeholders to make informed decisions in a landscape shaped by technological progress and evolving global influences. Organizations applying these insights can better position themselves for sustainable, strategic growth across this dynamic sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Immuno Oncology Assays Market, by Technology Type
8.1. Introduction
8.2. Flow Cytometry
8.2.1. Conventional Flow Cytometry
8.2.2. Spectral Flow Cytometry
8.3. Immunoassay
8.3.1. Elisa
8.3.2. Multiplex Immunoassay
8.4. Immunohistochemistry
8.4.1. Automated Ihc
8.4.2. Manual Ihc
8.5. Mass Cytometry
8.6. Next Generation Sequencing
8.6.1. Targeted Panel
8.6.2. Whole Exome Sequencing
8.6.3. Whole Genome Sequencing
9. Immuno Oncology Assays Market, by Application
9.1. Introduction
9.2. Companion Diagnostics
9.2.1. Predictive Diagnostics
9.2.2. Prognostic Diagnostics
9.3. Research Applications
9.3.1. Clinical Research
9.3.2. Preclinical Research
10. Immuno Oncology Assays Market, by End User
10.1. Introduction
10.2. Academic and Research Institutes
10.2.1. Research Institutes
10.2.2. Universities
10.3. Diagnostic Laboratories
10.3.1. Local Laboratories
10.3.2. Reference Laboratories
10.4. Hospitals and Clinics
10.4.1. General Hospitals
10.4.2. Oncology Centers
10.5. Pharmaceutical and Biotech
10.5.1. Big Pharmaceutical
10.5.2. Small Biotech
11. Immuno Oncology Assays Market, by Product
11.1. Introduction
11.2. Consumables
11.2.1. Probes and Antibodies
11.2.2. Reagents and Kits
11.3. Instruments
11.3.1. Automated Systems
11.3.2. Platform Based Instruments
12. Immuno Oncology Assays Market, by Indication
12.1. Introduction
12.2. Breast Cancer
12.3. Hematologic Cancers
12.4. Lung Cancer
12.5. Melanoma
13. Americas Immuno Oncology Assays Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Immuno Oncology Assays Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Immuno Oncology Assays Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Danaher Corporation
16.3.3. Merck KGaA
16.3.4. Agilent Technologies, Inc.
16.3.5. F. Hoffmann-La Roche Ltd
16.3.6. Bio-Rad Laboratories, Inc.
16.3.7. PerkinElmer, Inc.
16.3.8. QIAGEN N.V.
16.3.9. Illumina, Inc.
16.3.10. Becton, Dickinson and Company
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. IMMUNO ONCOLOGY ASSAYS MARKET MULTI-CURRENCY
FIGURE 2. IMMUNO ONCOLOGY ASSAYS MARKET MULTI-LANGUAGE
FIGURE 3. IMMUNO ONCOLOGY ASSAYS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 14. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. IMMUNO ONCOLOGY ASSAYS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. IMMUNO ONCOLOGY ASSAYS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. IMMUNO ONCOLOGY ASSAYS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SPECTRAL FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY MULTIPLEX IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY AUTOMATED IHC, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY MANUAL IHC, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY MASS CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TARGETED PANEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PREDICTIVE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PROGNOSTIC DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY LOCAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ONCOLOGY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY BIG PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SMALL BIOTECH, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PROBES AND ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY REAGENTS AND KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PLATFORM BASED INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY HEMATOLOGIC CANCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY MELANOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 101. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 102. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 103. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 104. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 105. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 106. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 108. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 109. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 111. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 112. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 113. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 114. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 116. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 117. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 118. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 119. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 120. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 121. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 122. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 123. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 125. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 126. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 128. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 129. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 130. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 131. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 133. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 134. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 156. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 157. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 159. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 160. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 163. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 198. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 200. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 202. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 204. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 205. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 206. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 207. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 208. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 209. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 211. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 212. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 214. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 215. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 216. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 217. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 218. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 219. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 220. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 221. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 222. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 223. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 224. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 225. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 226. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 228. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 229. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 231. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 232. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 233. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 234. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 235. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 236. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 237. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 238. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 239. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 240. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 241. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 242. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 243. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 245. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 246. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 248. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 249. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 250. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 251. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 252. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 253. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 254. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 255. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 256. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 257. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 258. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 259. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 260. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 262. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 263. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 265. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 266. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 267. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 268. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 269. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 270. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 271. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 272. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 273. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 274. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 275. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 276. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 277. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 279. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 280. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 281. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 282. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 283. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 284. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 285. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 286. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 287. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 288. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2030 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 303. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 305. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 306. SAUDI ARABIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 308. SAUDI ARABIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 310. SAUDI ARABIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 312. SAUDI ARABIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 314. SAUDI ARABIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
T

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Immuno Oncology Assays market report include:
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Merck KGaA
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Illumina, Inc.
  • Becton, Dickinson and Company

Table Information

Report AttributeDetails
No. of Pages195
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 8.33 Billion
Forecasted Market Value ( USD ) by 2030 $ 16.95 Billion
Compound Annual Growth Rate15.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Immuno Oncology Assays Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Immuno Oncology Assays Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 185 Pages
  • Global
From
Market Forecasts for Immuno-Oncology Diagnostics Including Executive/Consultant Guides and Customized Forecasting/Analysis - Product Image

Market Forecasts for Immuno-Oncology Diagnostics Including Executive/Consultant Guides and Customized Forecasting/Analysis

  • Report
  • 472 Pages
  • Global
From
Immuno-oncology Clinical Trials Market by Therapy Type, Trial Phase, Indication, Sponsor Type, Trial Type, Patient Enrollment - Global Forecast to 2030 - Product Image

Immuno-oncology Clinical Trials Market by Therapy Type, Trial Phase, Indication, Sponsor Type, Trial Type, Patient Enrollment - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
Immuno-Oncology Market by Therapy Type, Indication, End User, Line of Therapy, Mechanism - Global Forecast to 2030 - Product Image

Immuno-Oncology Market by Therapy Type, Indication, End User, Line of Therapy, Mechanism - Global Forecast to 2030

  • Report
  • 196 Pages
  • Global
From
Immuno-oncology Clinical Trials Market Size, Share & Trends Analysis Report By Phase, By Design (Interventional Trials, Observational Trials, Expanded Access Trials), By Indication, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Immuno-oncology Clinical Trials Market Size, Share & Trends Analysis Report By Phase, By Design (Interventional Trials, Observational Trials, Expanded Access Trials), By Indication, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From

About the Immuno Oncology Assays Market

Immuno Oncology Assays are tests used to measure the immune system's response to cancer. These tests are used to identify biomarkers that can be used to predict the effectiveness of immunotherapy treatments. Immuno Oncology Assays are used to measure the activity of the immune system, such as the number of T-cells, the presence of antibodies, and the expression of cytokines. These tests can also be used to monitor the progression of cancer and to determine the best course of treatment. Immune Disorders Drugs are used to treat a variety of conditions, including autoimmune diseases, allergies, and cancer. Immuno Oncology Assays are used to measure the effectiveness of these drugs and to monitor the progression of the disease. Some companies in the Immuno Oncology Assays market include Agilent Technologies, Bio-Rad Laboratories, Illumina, Merck, and Qiagen. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.